Theracryf Plc (AIM:TCF)
London · Delayed Price · Currency is GBP · Price in GBX 0.1950
0.00 (0.00%)
Aug 14, 2026, 4:24 PM GMT
Theracryf Market Cap
Theracryf has a market cap or net worth of 4.19 million as of August 14, 2026. Its market cap has decreased by -12.55% in one year.
Market Cap
4.19M
Enterprise Value
694.48K
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.20
ChartMarket Cap Chart
Since October 21, 2015, Theracryf's market cap has decreased from 25.60M to 4.19M, a decrease of -83.63%. That is a compound annual growth rate of -15.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 4.19M | -2.50% |
| Dec 31, 2025 | 4.30M | 90.55% |
| Dec 31, 2024 | 2.26M | -48.72% |
| Dec 29, 2023 | 4.40M | -64.04% |
| Dec 30, 2022 | 12.23M | -13.59% |
| Dec 31, 2021 | 14.16M | -0.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Solvonis Therapeutics | 9.67M |
| Cizzle Biotechnology Holdings | 7.01M |
| OptiBiotix Health | 5.94M |
| Thalia Therapeutics | 5.62M |
| Oxford BioDynamics | 5.58M |
| CRISM Therapeutics | 5.42M |
| Nuformix | 3.39M |
| Futura Medical | 2.81M |